BABY On Other Exchanges

natus medical inc (BABY) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NATUS MEDICAL INC (BABY)

Related News

No related news articles were found.

natus medical inc (BABY) Related Businessweek News

No Related Businessweek News Found

natus medical inc (BABY) Details

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.

1,729 Employees
Last Reported Date: 03/1/19
Founded in 1987

natus medical inc (BABY) Top Compensated Officers

President, CEO & Director
Total Annual Compensation: $574.8K
Executive VP & CFO
Total Annual Compensation: $568.7K
Executive VP & Chief Commercial Officer
Total Annual Compensation: $381.0K
VP of Quality, Regulatory Affairs & Chief Med...
Total Annual Compensation: $316.0K
Compensation as of Fiscal Year 2018.
natus medical inc
Natus Medical Incorporated Approves Amendments to Amended and Restated Certificate of Incorporation

At the Annual Meeting, stockholders of Natus Medical Incorporated, upon recommendation of the Company's Board of Directors, approved two amendments to Article FIFTH, Section 1 of the Company's Amended and Restated Certificate of Incorporation to declassify the Board and to eliminate cumulative voting. The stockholders approved the Amendments by a majority vote of the outstanding shares of the Company's common stock entitled to vote on the matter. On June 5, 2019, immediately following the vote of the Company's stockholders at the Annual Meeting, the Company filed a Certificate of Amendment to the Restated Charter of the Company with the Delaware Secretary of State to effect the Amendments, which became effective on June 5, 2019.

Natus Medical Incorporated Presents at William Blair 2019 Growth Stock Conference, Jun-06-2019 02:00 PM

Natus Medical Incorporated Presents at William Blair 2019 Growth Stock Conference, Jun-06-2019 02:00 PM. Venue: Loews Chicago Hotel, 455 North Drive, Chicago, Illinois, United States. Speakers: Benjamin Drew Davies, Executive VP & CFO.

Natus Medical Incorporated Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019; Provides Earnings Guidance for the Second Quarter Ending June 30, 2019; Updates Earnings Guidance for the Full Year Ending December 31, 2019; Reports Impairment of Intangible Assets Held for Sale

Natus Medical Incorporated announced unaudited consolidated earnings results for the first quarter ended March 31, 2019. For the period, the company reported revenue of $114,757,000 compared to $128,609,000 a year ago. Loss from operations was $37,619,000 compared to $2,728,000 a year ago. Net loss was $30,001,000 compared to $3,148,000 a year ago. Basic and diluted loss per share was $0.89 compared to $0.10 a year ago. For the first quarter of 2019, the company reported impairment charge on held for sale entity of $24,571,000. For the second quarter of 2019, the company's revenue guidance is expected to be between $121.0 million and $125.0 million. GAAP EPS is expected to be between $0.10 to $0.17. For the full year 2019, the company's revenue expected guidance was updated to be between $489.0 million and $505.0 million from $490.0 million and $510.0 million. GAAP EPS is expected to be between negative $0.25 to positive $0.02.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

BABY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BABY.
View Industry Companies

Industry Analysis


Industry Average

Valuation BABY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NATUS MEDICAL INC, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at